BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis

NCT02430532 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

58

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Multiple Sclerosis, Secondary Progressive

Interventions

DRUG: dimethyl fumarate
OTHER: Placebo

Sponsor

Biogen